MedTrace Logo

The Effect of Virtual Reality Glasses and Breathing Exercise on Anxiety

NCT07745946 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2026-08-06

No results posted yet for this study

Summary

This study was conducted to determine the effect of virtual reality glasses use and breathing exercise application on anxiety levels in breast cancer patients undergoing chemotherapy treatment.

Conditions

Interventions

BEHAVIORAL

Breathing exercise

Intervention 1: Breathing Exercise In this study, participants in the breathing exercise group will perform diaphragmatic (deep) breathing exercises during their chemotherapy sessions. Diaphragmatic breathing promotes deeper, more controlled respiration through effective use of the diaphragm muscle, producing a balancing effect on the autonomic nervous system, while slow rhythmic breathing supports relaxation by increasing heart rate variability. Participants will be guided by a nurse/researcher to perform the exercise for \[10 minutes\]

BEHAVIORAL

Virtual Reality Glasses

Intervention 2: Virtual Reality Glasses Participants in the virtual reality group will wear VR glasses displaying calming, distraction-based visual and auditory content during their chemotherapy infusion. This intervention aims to redirect attention away from the treatment process, thereby reducing perceived stress and anxiety. The VR session will be applied for \[10 minutes\]

Sponsors & Collaborators

  • Ankara Medipol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-15
Primary Completion
2026-04-15
Completion
2026-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07745946 on ClinicalTrials.gov